Obesity Trial, Recruiting NCT06416488 Sponsor: Children's Hospital of Fudan University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06416488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers between the ages of 7 and 18 at the start of the trial.
  • People who have at least one blood sugar abnormality, such as prediabetes (blood sugar levels that are higher than normal but not yet in the diabetes range).
  • People who have at least one abnormal cholesterol or fat level in their blood (such as low "good" cholesterol, high "bad" cholesterol, high triglycerides, or high total cholesterol).
  • People who have blood pressure that is consistently higher than expected for their age, gender, and height, or that meets a certain elevated threshold.
  • People whose parent or guardian provides written agreement for them to participate, along with their own written agreement.

Who may not be able to join:

  • People who have previously been diagnosed with heart failure, severe malnutrition, a weakened immune system, liver or kidney disease, cancer, or other conditions the trial site considers unsuitable.
  • People who are currently taking weight loss medications or who have had weight loss surgery.
  • People who have taken part in a structured exercise or diet program within the past year.
  • People who already do high-intensity interval training (HIIT) regularly (at least once a week).
  • People whose excess weight is caused by another underlying condition, such as a hormonal disorder, a neurological or psychiatric condition, or sleep apnea.
  • People who are unable to participate in the physical activities involved due to a health condition such as a joint problem, fracture, or injury.
  • People considered unsuitable for other reasons, as determined by the trial site (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8664932921

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital of Fudan University
Registry
ClinicalTrials.gov
Start date
13 July 2024
Est. completion
1 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Number of participants with reversal of at least one cardio-metabolic abnormalities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov